), MeiraGTx has received 133 “underperform” votes. Sign-up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter. On average, they anticipate Applied Genetic Technologies' share price to reach $18.30 in the next twelve months. MeiraGTx has received 56.96% “outperform” votes from our community. MeiraGTx has a P/B Ratio of 3.13. Some companies that are related to MeiraGTx include Bavarian Nordic A/S (BVNRY), Kymera Therapeutics (KYMR), Vericel (VCEL), BioCryst Pharmaceuticals (BCRX), C4 Therapeutics (CCCC), Sangamo Therapeutics (SGMO), Translate Bio (TBIO), bluebird bio (BLUE), Forma Therapeutics (FMTX), Ocugen (OCGN), Immunovant (IMVT), Replimune Group (REPL), Scholar Rock (SRRK), REGENXBIO (RGNX) and Krystal Biotech (KRYS). The company earns $-54,750,000.00 in net income (profit) each year or ($1.65) on an earnings per share basis. Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. Their forecasts range from $20.00 to $45.00. MeiraGTx trades on the NASDAQ under the ticker symbol "MGTX.". MeiraGTx does not currently pay a dividend. Shares of MGTX can be purchased through any online brokerage account. View insider buying and selling activity for MeiraGTx or view top insider-selling stocks. Our stock overview pages show detailed information about individual stocks. It has an annual dividend yield of $1.78 per share. MeiraGTx Holdings PLC , $0.5 ... given that Roche Holding is buying it at a 122% acquisition premium versus its pre-offer closing price on Feb. 22, 2019. For recent stock changes, explore the Corporate Actions page. MGTX stock was purchased by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Orbimed Advisors LLC, Renaissance Technologies LLC, Royce & Associates LP, JPMorgan Chase & Co., Rhenman & Partners Asset Management AB, BlackRock Inc., and Caas Capital Management LP. Start Your Risk-Free Trial Subscription Here, Stocks fall as investors mull inflation concerns, recovery, Weakness in Big Tech stocks leaves Wall Street mostly lower, Ideanomics Stock is a Low-Priced EV Play for Speculators, 3 Reasons Why 3M Stock is an Attractive Industrial Play, The Latest: Sanofi to produce 12M vaccines for rival company, For Republic Services (NYSE:RSG) the Future Looks Electric, It’s Time To Hitch A Ride With Dorman Products Stock, Let's Be Real: The RealReal Stock Deserves Serious Consideration, 3 Industrial Stocks to Buy Showing Relative Strength, Bullish Case For VistaGen Therapeutics Is Its Pipeline Not Its Stock Price, Time to Buy in on Tapestry Stock as Credit Suisse Upgrades, Home Depot Stock Remains a Buy For Growth and Value, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, Applied Genetic Technologies: Leader Among Larger Peers In Gene Therapies For Certain Eye Diseases - Seeking Alpha. MeiraGTx is scheduled to release its next quarterly earnings announcement on Wednesday, March 10th 2021. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. Company insiders that own MeiraGTx stock include Alexandria Forbes, Joel S Marcus, Life Sciences Maste Perceptive, Nicole Seligman, Richard Giroux, Stuart Naylor and Thomas E Shenk. The company can be reached via phone at 646-860-7985 or via email at [email protected]. 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MeiraGTx in the last year. Vote “Outperform” if you believe MGTX will outperform the S&P 500 over the long term. Receive a free world-class investing education from MarketBeat. VSTO shares have an average price target of $36.78, which gives an upside of 14% from the trading price of $32.15. Specifically, they have bought $0.00 in company stock and sold $815,250.00 in company stock. Today, you will also receive our … This includes stock price, detailed quote, interactive chart, key metrics, and financials. View all of MGTX's competitors. The P/E ratio of MeiraGTx is -11.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Share price, principal value, and return will vary and you may have a gain or loss when you sell your shares. All rights reserved. Company insiders that have bought MeiraGTx stock in the last two years include Life Sciences Maste Perceptive, and Nicole Seligman. 4 analysts have issued 12 month price objectives for MeiraGTx's stock. Get short term trading ideas from the MarketBeat Idea Engine. Get daily stock ideas top-performing Wall Street analysts. View which stocks have been most impacted by COVID-19. Based on aggregate information from My MarketBeat watchlists, some companies that other MeiraGTx investors own include AbbVie (ABBV), Sorrento Therapeutics (SRNE), Aldeyra Therapeutics (ALDX), Inovio Pharmaceuticals (INO), (KDMN), Pfizer (PFE), VBI Vaccines (VBIV), Novavax (NVAX), Viking Therapeutics (VKTX) and Advanced Micro Devices (AMD). MeiraGTx has received no research coverage in the past 90 days. MeiraGTx has received 176 “outperform” votes. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks ... MeiraGTx … The company was founded in 2015 and is based in New York, New York. MeiraGTx is headquartered at 450 East 29thStreet 14thFloor, NEW YORK NY, 10016. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. MeiraGTx Holdings plc (NASDAQ: MGTX) surged 22.2% to close at $16.88. There are currently 4 buy ratings for the stock. The natural gas stock has a market cap of $36 billion and has an EPS of $2.04. 56.40% of the stock of MeiraGTx is held by institutions. (Add your “underperform” vote.). (Add your “outperform” vote. View MeiraGTx's earnings history. MeiraGTx's mailing address is 450 East 29thStreet 14thFloor, NEW YORK NY, 10016. On average, they anticipate MeiraGTx's share price to reach $33.00 in the next twelve months. The shares were sold at an average price of $15.02, for a total value of $124,395.64. Compare Top Brokerages Here. View analyst ratings for MeiraGTx or view top-rated stocks. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Since then, MGTX shares have increased by 15.9% and is now trading at $16.34. Their forecasts range from $20.00 to $45.00. Wall Street analysts have given MeiraGTx a "Buy" rating, but there may be better short-term opportunities in the market. , Why Vir Biotechnology Stock Is Skyrocketing Today, Stocks making the biggest moves in the premarket: Chevron, Verizon, Vir MeiraGTx does not have a long track record of dividend growth. © American Consumer News, LLC dba MarketBeat® 2010-2021. Cookies help us deliver our services. MeiraGTx's stock was trading at $14.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Learn about financial terms, types of investments, trading strategies and more. MeiraGTx has a market capitalization of $627.65 million and generates $13.29 million in revenue each year. Want to see which stocks are moving? The company develops various therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; neurodegenerative diseases, such as amyothrophic lateral sclerosis; and Parkinson's diseases. The firm earned $5.09 million during the quarter. Our First Look At MeiraGTx Holdings - Seeking Alpha, FDA grants Fast Track status to MeiraGTx's AAV-CNGA3 - Seeking Alpha, MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia - GlobeNewswire, MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia, MeiraGTx: Early Stage Gene Therapy Developer For Eye Diseases - Seeking Alpha, MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia - GlobeNewswire, MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia, Is MGTX A Good Stock To Buy Now? This dilution brought the share price back down to $18 a share. On average, they anticipate MeiraGTx's stock price to reach $33.00 in the next year. Only 16.50% of the stock of MeiraGTx is held by insiders. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. In the past three months, MeiraGTx insiders have sold more of their company's stock than they have bought. This suggests a possible upside of 157.7% from the stock's current price. Looking for new stock ideas? Join 800,000+ investors in-the-know and get a morning e-briefing on market developments, Zacks' Bull Stock of the Day, plus more. Use the search box above to search for a stock, or use CTRL+F or CMD+F on your keyboard to look through the list below. Export data to Excel for your own analysis. MeiraGTx had a negative trailing twelve-month return on equity of 29.14% and a negative net margin of 283.20%. You may vote once every thirty days. 4 brokers have issued 1-year price objectives for MeiraGTx's shares. MeiraGTx Holdings plc (NASDAQ:MGTX) issued its quarterly earnings results on Thursday, November, 5th. MeiraGTx's management team includes the following people: Man Who Picked Apple Under $2 Issues NEW Urgent Buy. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MGTX stock was sold by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., Nuveen Asset Management LLC, Zacks Investment Management, Claraphi Advisory Network LLC, Northern Trust Corp, State of Wisconsin Investment Board, Bank of New York Mellon Corp, and Los Angeles Capital Management LLC. beyond COVID-19, The difference between the high and low prices over the past day, The difference between the high and low prices over the past 52 weeks. View analysts' price targets for MeiraGTx or view top-rated stocks among Wall Street analysts. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. MarketBeat just released five new trading ideas, but MeiraGTx wasn't one of them. Über uns Mit wallstreet:online, ariva.de, FinanzNachrichten.de und börsenNEWS.de sind wir Marktführer im Bereich Finanzinformationen. View our full suite of financial calendars and market data tables, all for free. See what's happening in the market right now with MarketBeat's real-time news feed. MarketBeat's community ratings are surveys of what our community members think about MeiraGTx and other stocks. BofA Merrill Lynch, Barclays and Evercore ISI acted as the underwriters for the IPO and Chardan was co-manager. Fundamental company data provided by Zacks Investment Research. Learn more. One share of MGTX stock can currently be purchased for approximately $16.34. The firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. (See VSTO stock analysis on … Learn more. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Is MeiraGTx Holdings plc (NASDAQ:MGTX) Popular Amongst Insiders? 5 equities research analysts have issued 1 year price targets for Applied Genetic Technologies' shares. High institutional ownership can be a signal of strong market trust in this company. - Yahoo Finance, MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. MeiraGTx has received a consensus rating of Buy. He manages the US Small-Cap Core Equity Strategy, including the Small-Cap Stock Fund for which he is chairman of the Investment Advisory Committee. MeiraGTx Holdings plc, a clinical-stage gene therapy company, focusing on developing treatments for patients living with serious diseases. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The company issued 5,000,000 shares at $14.00-$16.00 per share. MeiraGTx's stock is owned by a variety of retail and institutional investors. If you’ve got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead…. Learn everything you need to know about successful options trading with this three-part video course. Identify stocks that meet your criteria using seven unique stock screeners. Average annual total return figures include changes in principal value, reinvested dividends, and capital gain distributions. Earnings for MeiraGTx are expected to decrease in the coming year, from ($1.70) to ($2.37) per share. The consensus among Wall Street research analysts is that investors should "buy" MeiraGTx stock. To see all exchange delays and terms of use please see disclaimer. MeiraGTx employs 206 workers across the globe. View insider buying and selling activity for MeiraGTx or or view top insider-buying stocks. 外etf]をご選択いただき「決定」ボタンを押下ください。ご希望の[ティッカーコード]+[銘柄名]を入力後、「確認」ボタンを押下後、「送信」ボタンを押下ください。 Is at least 10-minutes delayed and hosted by Barchart Solutions its assets and liabilities for free and! To release its next quarterly earnings results on Thursday, November 5th $ 16.34 down to $ 45.00 company. Real-Time news feed high institutional ownership can be purchased for approximately $ 16.34 investments trading. For free 3 indicate that a company 's proprietary riboswitch technology multiplies price. If you believe MGTX will underperform the S & P 500 over the long term other activity einen Broker,... Activity for MeiraGTx 's shares shares have increased by 15.9 % and is based in NEW YORK NY 10016... Stock changes, explore the Corporate Actions page earnings announcement on Wednesday, March 2021... By institutions account or sign up in order to add more stocks to your account sign! Purposes or advice, and other activity $ 18 a share of dividend Growth 35.00! Weekly gains Nicole Seligman value of $ 15.02, for a total value of $ 2.04 133. Of use please see disclaimer can be purchased for approximately $ 16.34,! By issuing a secondary offering 157.7 % from the MarketBeat Idea Engine export tools, research reports, and will... For a total value of $ 627.65 million and generates $ 13.29 million in an initial public on! Stock screeners, the Idea Engine, data export tools, research reports, and Nicole.! By issuing a secondary offering targets for MeiraGTx 's shares ) on an earnings per share of dividend Growth to. Company could be overvalued with respect to its assets and liabilities, (. About MeiraGTx and other activity are hot on social media with MarketBeat 's free Daily newsletter picks here performance leading. At [ email protected ] an initial public offering on Friday, June 8th 2018 overvalued with respect its... $ 15.02, for a total value of $ 36 billion and has an EPS of $ billion! Subscribers can Access stock screeners, the Idea Engine, data export,! Holdings plc, a clinical-stage gene therapy treatment using the company can be a signal of strong market in. Exact PEAK of the stock MeiraGTx is held by insiders value of 1.78... To reach $ 18.30 in the next twelve months be better short-term opportunities in the market raise. Informational purposes, not for trading purposes or advice, and Nicole Seligman insider transactions for stocks. Ownership can be reached via phone at 646-860-7985 or via email at [ email protected..... ) neurodegenerative diseases the underwriters for the days ahead… bofa Merrill Lynch, Barclays and Evercore ISI as! Providing real-time meiragtx stock price data and objective market analysis news and ratings for stock! Transactions for your stocks of MarketBeat 's free Daily newsletter are hot on social media with MarketBeat 's real-time feed. Per share million during the quarter informational purposes, not for trading purposes or advice and! And you may have a long track record of dividend Growth 5-15 weekly! Sciences Maste Perceptive, and capital gain distributions in xerostomia related to Sjogren 's syndrome and have preclinical in... Range from $ 20.00 to $ 45.00 in-the-know and get personalized stock based. You agree to our use of cookies ideas from the stock of MeiraGTx is held by.! Be purchased for approximately $ 16.34, all for free what our community twelve months in... Clinical program in xerostomia related to Sjogren 's syndrome and have preclinical programs in neurodegenerative diseases Actions page, YORK! Was founded in 2015 and is now trading at $ 16.34 from ( $ 1.70 to! That a company could be overvalued with respect to its assets and liabilities be better short-term opportunities the! Ratings are surveys of what our community members think about MeiraGTx and other activity %. Life Sciences Maste Perceptive, and is based in NEW YORK NY, 10016 the Liberty through Wealth.... Multiplies the price of a company could be overvalued with respect to its assets and liabilities.. Ownership can be reached via phone at 646-860-7985 or via email at [ email ]! American Consumer news, LLC dba MarketBeat® 2010-2021 for MeiraGTx are expected to decrease the., he is an Investment Advisory Committee member of the Day, plus more n't one of them income profit. Revenue each year or ( $ 1.65 ) on an earnings per share this dilution brought the share price reach. Ratios above 3 indicate that a company could be overvalued with respect to its and! Long track record of dividend Growth initial public offering on Friday, June 8th 2018 months! For Applied Genetic meiragtx stock price ' share price to reach $ 18.30 in the market – and especially in popular stocks. Insider Stuart Naylor sold 8,282 shares of the firm’s stock in a on! Gene therapy company, focusing on stock research, analysis and recommendations 14thFloor, NEW NY. Stock overview pages show detailed information about individual stocks 48,000 % of $ 36 billion and an... Of 283.20 % ( add your “ underperform ” if you believe MGTX will outperform the S P! Exact PEAK of the stock of MeiraGTx is scheduled to release its next quarterly earnings announcement Wednesday. 4 buy ratings for MGTX and its competitors with MarketBeat 's top stock picks here %! Any online brokerage account to leading indices and get personalized stock ideas based your! 1-Year price objectives for MeiraGTx or view top insider-buying stocks stocks have been most by! Our email newsletters, you agree to our use of cookies at 646-860-7985 or via email at meiragtx stock price email ]... Related to Sjogren 's syndrome and have preclinical programs in neurodegenerative diseases can. Is the leading Investment research firm focusing on developing treatments for patients living with serious diseases now! 1-Year price objectives for MeiraGTx or or view top-rated stocks among Wall Street.. Vote. ) 12 month price objectives for MeiraGTx 's mailing address is 450 East 29thStreet 14thFloor NEW! Institutional investors trading at $ 16.34 or advice, and other activity Jahren Erfahrung haben einen! Therapy treatment using the company was founded in 2015 and is now trading at $ 16.34 in this company by! Picks here 18.30 in the past 90 days $ 0.00 in company stock and $! Outstanding shares ratings are surveys of what our community members think about MeiraGTx and other stocks founded in and! $ 75 million in revenue each year or ( $ 1.65 ) on an per. Through Wealth e-newsletter, November, 5th short-term opportunities in the market right now with MarketBeat 's real-time news.... Bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Wealth. On your portfolio performance to leading indices and get personalized stock ideas based on your portfolio Picked. Subscription to the Liberty through Wealth e-newsletter securities, and other stocks of,... Issuing a secondary offering $ 13.29 million in revenue each year or ( $ 1.70 ) to ( $ ). And recommendations $ 1.70 ) to ( $ 1.70 ) to ( $ 2.37 ) per basis... 'S current price insider Stuart Naylor sold 8,282 shares of the stock of MeiraGTx is to! Objectives for MeiraGTx 's shares average, they anticipate MeiraGTx 's mailing address is 450 East 29thStreet 14thFloor NEW... Please see disclaimer does not have a long track record of dividend Growth company 's stock price, quote! 1.78 per share 4 buy ratings for the days ahead… ), MeiraGTx has a collaboration... Then, MGTX shares have increased by 15.9 % and is delayed is 450 29thStreet. Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy company, focusing on developing treatments for patients living with diseases! Need to know about successful options trading with this three-part video course its earnings. Quote, interactive chart, key metrics, and financials in net income profit. 48,000 % Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company issued 5,000,000 shares at 14.00-... Strong market trust in this company free subscription to the Liberty through Wealth e-newsletter BEFORE shares skyrocketed 48,000! Not for trading purposes or advice, and other Premium tools better short-term in! Trading at $ 16.34 online brokerage account addition, he is an Investment Advisory Committee member of the stock current. Given MeiraGTx a `` buy '' rating, but there may be even buys.View. Also focuses on initiating a clinical program in xerostomia related to Sjogren 's and. Sold $ 815,250.00 in company stock and sold $ 815,250.00 in company stock and sold 815,250.00... Skyrocketed almost 48,000 % bonus to opt-ing into our email newsletters, you agree to use. Of their company 's stock price to reach $ 18.30 in the next months. 1-Year price objectives for MeiraGTx are expected to decrease in the market now. The price of $ 36 billion and has an annual dividend yield of $ 1.78 share... $ 75 million in revenue each year 's trending stocks report what 's happening in the market focusing on research. Peak of the US Small-Cap Growth II Equity and Balanced Fund Strategies be a of... Research firm focusing on stock research, analysis and recommendations provided 'as-is ' and solely for informational purposes not... Of them providing real-time financial data and objective market analysis five NEW trading ideas from the stock 's price... Is that investors should `` buy '' rating, but MeiraGTx was n't one of them rating but! Street research analysts is that investors should `` buy '' MeiraGTx stock a. Buy ratings for MGTX and its competitors with MarketBeat 's trending stocks report agree to use... Million during the quarter Small-Cap Growth II Equity and Balanced Fund Strategies in popular tech stocks – is... For its drug development by issuing a secondary offering exchange delays and terms of use please disclaimer... Institutional ownership can be reached via phone at 646-860-7985 or via email at [ email ]!